Sandra Larkin

2.0k total citations
58 papers, 1.4k citations indexed

About

Sandra Larkin is a scholar working on Genetics, Physiology and Hematology. According to data from OpenAlex, Sandra Larkin has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 18 papers in Physiology and 15 papers in Hematology. Recurrent topics in Sandra Larkin's work include Hemoglobinopathies and Related Disorders (39 papers), Erythrocyte Function and Pathophysiology (14 papers) and Hemoglobin structure and function (11 papers). Sandra Larkin is often cited by papers focused on Hemoglobinopathies and Related Disorders (39 papers), Erythrocyte Function and Pathophysiology (14 papers) and Hemoglobin structure and function (11 papers). Sandra Larkin collaborates with scholars based in United States, United Kingdom and Canada. Sandra Larkin's co-authors include Frans A. Kuypers, Lori Styles, Elliott Vichinsky, Claudia R. Morris, Nancy Sweeters, Ward Hagar, Kitty de Jong, Nikole Neidlinger, Carolyn Hoppe and Robert M. Bookchin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Sandra Larkin

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Larkin United States 20 889 625 418 325 205 58 1.4k
Jeroen S. Goede Switzerland 18 506 0.6× 671 1.1× 435 1.0× 273 0.8× 216 1.1× 49 1.3k
Mary B. Palascak United States 16 426 0.5× 319 0.5× 493 1.2× 236 0.7× 154 0.8× 19 1.1k
Yelena Ginzburg United States 22 1.6k 1.8× 1.7k 2.6× 524 1.3× 388 1.2× 137 0.7× 84 2.4k
Yves Pastore Canada 17 402 0.5× 477 0.8× 157 0.4× 303 0.9× 100 0.5× 60 1.1k
Jaroslav F. Prchal Canada 19 1.5k 1.7× 1.5k 2.3× 349 0.8× 676 2.1× 102 0.5× 39 2.4k
Joan D. Beckman United States 13 274 0.3× 209 0.3× 107 0.3× 337 1.0× 97 0.5× 31 754
Francisco Bautista Spain 18 325 0.4× 144 0.2× 157 0.4× 329 1.0× 163 0.8× 74 1.1k
P. M. Mannucci Italy 20 258 0.3× 857 1.4× 70 0.2× 169 0.5× 185 0.9× 45 1.3k
Orly Zelig Israel 15 117 0.1× 299 0.5× 270 0.6× 172 0.5× 143 0.7× 35 877
Fausto Adami Italy 21 345 0.4× 319 0.5× 83 0.2× 471 1.4× 86 0.4× 50 1.5k

Countries citing papers authored by Sandra Larkin

Since Specialization
Citations

This map shows the geographic impact of Sandra Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Larkin more than expected).

Fields of papers citing papers by Sandra Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Larkin. The network helps show where Sandra Larkin may publish in the future.

Co-authorship network of co-authors of Sandra Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Larkin. A scholar is included among the top collaborators of Sandra Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Larkin. Sandra Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ericsson, Anna, David J. Richard, Erik Wilker, et al.. (2024). FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Experimental Hematology. 141. 104673–104673. 1 indexed citations
2.
Larkin, Sandra, et al.. (2024). The RoxyScan is a novel measurement of red blood cell deformability under oxidative and shear stress. Scientific Reports. 14(1). 6344–6344. 3 indexed citations
3.
Larkin, Sandra, et al.. (2023). Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot study. Pediatric Blood & Cancer. 70(8). e30423–e30423. 5 indexed citations
4.
Morris, Claudia R., Frans A. Kuypers, Sandra Larkin, et al.. (2022). Implications for the metabolic fate of oral glutamine supplementation within plasma and erythrocytes of patients with sickle cell disease: A pharmacokinetics study. Complementary Therapies in Medicine. 64. 102803–102803. 4 indexed citations
5.
Waqar, Mueez, Ajai Chari, Abdurrahman I. Islim, et al.. (2021). Chlorhexidine dressings could reduce external ventricular drain infections: results from a systematic review and meta-analysis. Journal of Hospital Infection. 117. 37–43. 8 indexed citations
6.
Fens, Marcel H.A.M., Pedro Cabrales, Jan Scicinski, et al.. (2016). Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation. Medical Oncology. 33(8). 85–85. 10 indexed citations
7.
Cabrales, Pedro, Jan Scicinski, Tony Reid, et al.. (2016). A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?. Medical Oncology. 33(7). 63–63. 13 indexed citations
8.
Soupène, Eric, et al.. (2016). Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood. Experimental Biology and Medicine. 241(17). 1933–1942. 13 indexed citations
9.
Morris, Claudia R., Hae‐Young Kim, Elizabeth S. Klings, et al.. (2015). Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. British Journal of Haematology. 169(6). 887–898. 18 indexed citations
10.
Fens, Marcel H.A.M., et al.. (2014). The Capacity of Red Blood Cells to Reduce Nitrite Determines Nitric Oxide Generation under Hypoxic Conditions. PLoS ONE. 9(7). e101626–e101626. 26 indexed citations
11.
Singer, Sylvia T., Frans A. Kuypers, Ginny Gildengorin, et al.. (2014). Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Annals of Hematology. 93(7). 1139–1148. 16 indexed citations
12.
Morris, Claudia R., John C. Wood, John B. Porter, et al.. (2013). Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 98(9). 1359–1367. 33 indexed citations
13.
Mansour, Karim, et al.. (2010). Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED. The American Journal of Emergency Medicine. 29(9). 1163–1168. 6 indexed citations
14.
Hoppe, Carolyn, Sandra Larkin, James K. Liao, et al.. (2009). The Effect of Short-Term Simvastatin On Markers of Vascular Dysfunction in Patients with Sickle Cell Disease (SCD).. Blood. 114(22). 260–260. 2 indexed citations
15.
Singer, Sylvia T., Elliott Vichinsky, Sandra Larkin, et al.. (2008). Hydroxycarbamide‐induced changes in E/beta thalassemia red blood cells. American Journal of Hematology. 83(11). 842–845. 19 indexed citations
16.
Neidlinger, Nikole, et al.. (2005). Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. Journal of the American College of Surgeons. 200(2). 173–178. 19 indexed citations
17.
Neidlinger, Nikole, et al.. (2005). Hydrolysis of Phosphatidylserine-exposing Red Blood Cells by Secretory Phospholipase A2 Generates Lysophosphatidic Acid and Results in Vascular Dysfunction. Journal of Biological Chemistry. 281(2). 775–781. 85 indexed citations
18.
Morris, Claudia R., Frans A. Kuypers, Gregory J. Kato, et al.. (2005). Hemolysis‐Associated Pulmonary Hypertension in Thalassemia. Annals of the New York Academy of Sciences. 1054(1). 481–485. 83 indexed citations
19.
Morris, Claudia R., Frans A. Kuypers, Sandra Larkin, et al.. (2000). Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. British Journal of Haematology. 111(2). 498–500. 98 indexed citations
20.
Morris, Carole, Frans A. Kuypers, Sandra Larkin, et al.. (2000). Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. SHORT REPORT. British Journal of Haematology. 111(2). 498–500. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeroen S. Goede Breakdown of academic impact, for papers by Mary B. Palascak Breakdown of academic impact, for papers by Yelena Ginzburg Breakdown of academic impact, for papers by Yves Pastore Breakdown of academic impact, for papers by Jaroslav F. Prchal Breakdown of academic impact, for papers by Joan D. Beckman Breakdown of academic impact, for papers by Francisco Bautista Breakdown of academic impact, for papers by P. M. Mannucci Breakdown of academic impact, for papers by Orly Zelig Breakdown of academic impact, for papers by Fausto Adami
Rankless by CCL
2026